Infectious Diseases (ID) represent a major cause of morbidity and death worldwide. The increased incidence of certain ID has resulted in the continuous development of novel molecular diagnostic methods, which result in quicker and more accurate diagnosis of the aetiological agent. These new molecular tests have revolutionised ID testing, delivering improved diagnosis and monitoring of treatment and disease progression.
The DiaSorin Solution offer the complete workflow form primary sample to results thanks to the LIAISON® Ixt extraction platform, followed by amplification throught the novel Q-LAMP technology onto the dedicated DiaSorin Iam analyzer.
The LIAISON® Ixt system can extract nucleic acid from a variety of sample types thanks to the several extraction kits available.
Thanks to the addition of an exogeneous internal control, the extracted nucleic acid can be directly moved into the molecular detection step by Q-LAMP.